Participants in clinical trials should reflect the diversity of the population, with particular attention to those most affected by the disease. A lack of representation from racial/ethnic minority groups in clinical trials has resulted in the development of interventions that have not translated well into real-world use and have not been efficacious in different populations.
You can be the change you want to see in the world, as you learn more about chronic diseases and illness that plague the communities of black, indeginous and people of color. Understand the disease/illness, know the symptoms, learn about the treatment choices and navigate the healthcare system to get the best regiments of care and medical pharmaceuticals.
The prevalence of high blood pressure differs by race/ethnicity, with the condition being more common among blacks (40.4%) compared with whites (27.4%) and Mexican-Americans (26.1%). - CDC 2013
Racial and ethnic minorities have a higher burden of diabetes, worse diabetes control and are more likely to experience complications (for example, among Hispanics, the death rate from diabetes is 50% higher than for non-Hispanic whites) - FDA/Office of Minority Health and Health Equity
Historical racism, oppression and violence makes it extremely difficult to access treatment and manage mental health illnesses.
Prostate cancer death rates in black men are more than double those of every other racial/ethnic group
The most recent U.S. maternal mortality ratio, or rate, of 17.4 per 100,000 pregnancies represented approximately 660 maternal deaths in 2018. This ranks last overall among industrialized countries. More than half of recorded maternal deaths occur after the day of birth.
Black women are 40% more likely to die of breast cancer than white women and are twice as likely to die if they are over 50
The infectious disease categories with a significantly higher rate ratio among Blacks, even after adjustment for family income and education, were tuberculosis, HIV/AIDS, septicemia, and infections of the kidneys and urinary tract.
33% of American adults are at risk for kidney disease. Yes, one in three people. Black or African Americans are almost 4 times more likely and Hispanics or Latinos are 1.3 times more likely to have kidney failure compared to White Americans.
Glaucoma occurs about five times more often in African Americans. Blindness from glaucoma is about six times more common. In addition to this higher frequency, glaucoma often occurs earlier in life in African Americans — on average, about 10 years earlier than in other ethnic populations.
Ethnic minority populations have been identified as high users of traditional, complementary and alternative medicine (TCAM).
Among Mexican Americans, 13.1 percent have osteoporosis and 42.2 percent have low bone mass. Among black Americans, 4.2 percent have osteoporosis and 29.7 percent have low bone mass. African Americans have a lower risk of breaking a bone in their lifetime, compared to white Americans and other ethnic groups.
A lack of representation from racial/ethnic minority groups in clinical trials has resulted in the development of interventions that have not translated well into real-world use and have not been efficacious in different populations.